Use of biological therapy to enhance both virotherapy and adoptive T-cell therapy for cancer.
Kottke T, Diaz RM, Kaluza K, Pulido J, Galivo F, Wongthida P, Thompson J, Willmon C, Barber GN, Chester J, Selby P, Strome S, Harrington K, Melcher A, Vile RG.
Kottke T, et al.
Mol Ther. 2008 Dec;16(12):1910-8. doi: 10.1038/mt.2008.212. Epub 2008 Sep 30.
Mol Ther. 2008.
PMID: 18827807
Free PMC article.